1. Home
  2. ATOM vs PLX Comparison

ATOM vs PLX Comparison

Compare ATOM & PLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Atomera Incorporated

ATOM

Atomera Incorporated

BUY

Current Price

$2.98

Market Cap

157.7M

Sector

Technology

ML Signal

BUY

Logo Protalix BioTherapeutics Inc. (DE)

PLX

Protalix BioTherapeutics Inc. (DE)

HOLD

Current Price

$2.56

Market Cap

207.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ATOM
PLX
Founded
2001
1993
Country
United States
United States
Employees
N/A
N/A
Industry
Semiconductors
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
157.7M
207.1M
IPO Year
2016
1996

Fundamental Metrics

Financial Performance
Metric
ATOM
PLX
Price
$2.98
$2.56
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
515.6K
★ 836.2K
Earning Date
10-29-2026
08-12-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 4.41
N/A
EPS
N/A
★ 0.27
Revenue
$62,000.00
★ $52,744,000.00
Revenue This Year
$361.54
$55.77
Revenue Next Year
$233.33
N/A
P/E Ratio
★ N/A
$9.46
Revenue Growth
N/A
★ N/A
52 Week Low
$1.89
$1.65
52 Week High
$12.37
$3.19

Technical Indicators

Market Signals
Indicator
ATOM
PLX
Relative Strength Index (RSI) 24.28 42.44
Support Level $2.25 $2.21
Resistance Level $3.51 $2.75
Average True Range (ATR) 0.23 0.10
MACD -0.09 -0.02
Stochastic Oscillator 4.09 19.67

Price Performance

Historical Comparison
ATOM
PLX

About ATOM Atomera Incorporated

Atomera Inc is engaged in the business of developing, commercializing, and licensing proprietary processes and technologies for the semiconductor industry. The company's technology, named Mears Silicon Technology, or MST, is a thin film of re-engineered silicon, typically 100 to 300 angstroms (or approximately 20 to 60 silicon atomic unit cells) thick. MST can be applied as a transistor channel enhancement to CMOS-type transistors, the majority of widely used in the semiconductor industry. The company's silicon technology can be used for applications like Analog, DRAM, logic, processors, and SRAM. Geographically, it generates maximum revenue from North America.

About PLX Protalix BioTherapeutics Inc. (DE)

Protalix BioTherapeutics Inc is a commercial-stage biopharmaceutical company focused on the discovery, development, production, and commercialization of therapeutics for rare diseases with important unmet needs. ProCellEx, a proprietary plant cell-based protein expression system, represents a new method for developing recombinant proteins in an industrial-scale manner. corporate includes the development of treatments for rare and orphan diseases. The Company operates as a single operating segment in Israel.

Share on Social Networks: